Jakub Qazi

Jakub Qazi, our Executive Regulatory and Clinical Affairs Advisor has a Master’s in pharmaceutical sciences from Université de Montréal and graduate degree in business administration from HEC Montréal. He has over two years of experience in multisite cohort study coordination, scientific writing, and statistical analysis through his work at the Canadian Consortium on Neurodegeneration in Aging and Université de Montréal, respectively. Trained in clinical research study design, real-world study design, and biostatistics, he was involved in the preparation of multiple published manuscripts. As our Executive Regulatory and Clinical Affairs Advisor, he participates in regulatory strategy (pre-IDE, IDE, and 510k preparation, their submission, associated non-clinical test planning, associated risk management planning and associated post-market oversight planning) as well as clinical trial drafting and management.